Alterations of axis inhibition protein 1 (AXIN1) in hepatitis B virus-related hepatocellular carcinoma and overexpression of AXIN1 induces apoptosis in hepatocellular cancer cells

Oncology Research

Volumn 20, Issue 7, 2013, Pages 281-288

  Li, Jiequn ^a   Quan, Hu ^b   Liu, Qiang ^b   Si, Zhongzhou ^a   He, Zhijun ^a   Qi, Haizhi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

Author keywords

Axis inhibition protein 1 (AXIN1); Gene therapy; Hepatocellular carcinoma (HCC); Mutation

Indexed keywords

AXIS INHIBITION PROTEIN 1; BETA CATENIN; CYCLIN D1; PROTEIN; REGULATOR PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL GROWTH; FEMALE; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SOMATIC MUTATION; SOUTHERN BLOTTING; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

EID: 84878925515     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13639794277608     Document Type: Article

References (29)

1. Nguyen, V. T.; Law, M. G.; Dore, G. J. Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden. J. Viral Hepat. 16:453-463; 2009.
2. Tan, X.; Yuan, Y.; Zeng, G.; Apte, U.; Thompson, M. D.; Cieply, B.; Stolz, D. B.; Michalopoulos, G. K.; Kaestner, K. H.; Monga, S. P. β-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 47:1667-1679; 2008.
3. Nejak-Bowen, K. N.; Thompson, M. D.; Singh, S.; Bowen, Jr., W. C.; Dar, M. J.; Khillan, J.; Dai, C.; Monga, S. P. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant β-catenin. Hepatology 51:1603-1613; 2010.
4. Satoh, S.; Daigo, Y.; Furukawa, Y.; Kato, T.; Miwa, N.; Nishiwaki, T.; Kawasoe, T.; Ishiguro, H.; Fujita, M.; Tokino, T.; Sasaki, Y.; Imaoka, S.; Murata, M.; Shimano, T.; Yamaoka, Y.; Nakamura, Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24: 245-250; 2000.
5. Cavard, C.; Terris, B.; Grimber, G.; Christa, L.; Audard, V.; Radenen-Bussiere, B.; Simon, M. T.; Renard, C. A.; Buendia, M. A.; Perret, C. Overexpression of regenerating islet-derived 1α and 3α genes in human primary liver tumors with β-catenin mutations. Oncogene 25:599-608; 2006.
6. Cui, J.; Zhou, X.; Liu, Y.; Tang, Z.; Romeih, M. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of β-catenin, T-cell factor-4 and glycogen synthase kinase-3β genes. J. Gastroenterol. Hepatol. 18:280-287; 2003.
7. Giles, R. H.; van Es, J. H.; Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653:1-24; 2003.
8. Ito, T.; Shiraki, K.; Sugimoto, K.; Yamanaka, T.; Fujikawa, K.; Ito, M.; Takase, K.; Moriyama, M.; Kawano, H.; Hayashida, M.; Nakano, T.; Suzuki, A. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085; 2000.
9. Liu, Y. C.; Chen, C. J.; Wu, H. S.; Chan, D. C.; Yu, J. C.; Yang, A. H.; Cheng, Y. L.; Lee, S. C.; Harn, H. J. Telomerase and c-myc expression in hepatocellular carcinomas. Eur. J. Surg. Oncol. 30:384-390; 2004.
10. Masaki, T.; Shiratori, Y.; Rengifo, W.; Igarashi, K.; Yamagata, M.; Kurokohchi, K.; Uchida, N.; Miyauchi, Y.; Yoshiji, H.; Watanabe, S.; Omata, M.; Kuriyama, S. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37:534-543; 2003.
11. Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127:469-480; 2006.
12. Zeng, L.; Fagotto, F.; Zhang, T.; Hsu, W.; Vasicek, T. J.; Perry, 3rd, W. L.; Lee, J. J.; Tilghman, S. M.; Gumbiner, B. M.; Costantini, F. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181-192; 1997.
13. Taniguchi, K.; Roberts, L. R.; Aderca, I. N.; Dong, X.; Qian, C.; Murphy, L. M.; Nagorney, D. M.; Burgart, L. J.; Roche, P. C.; Smith, D. I.; Ross, J. A.; Liu, W. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863-4871; 2002.
14. Zucman-Rossi, J.; Benhamouche, S.; Godard, C.; Boyault, S.; Grimber, G.; Balabaud, C.; Cunha, A. S.; Bioulac-Sage, P.; Perret, C. Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas. Oncogene 26:774-780; 2007.
15. Laurent-Puig, P.; Legoix, P.; Bluteau, O.; Belghiti, J.; Franco, D.; Binot, F.; Monges, G.; Thomas, G.; Bioulac- Sage, P.; Zucman-Rossi, J. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120:1763-1773; 2001.
16. Ku, J. L.; Park, J. G. Biology of SNU cell lines. Cancer Res. Treat . 37:1-19; 2005.
17. Kurihara, T.; Ikeda, S.; Ishizaki, Y.; Fujimori, M.; Tokumoto, N.; Hirata, Y.; Ozaki, S.; Okajima, M.; Sugino, K.; Asahara, T. Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. Thyroid 14:1020-1029; 2004.
18. Morin, P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790; 1997.
19. de La Coste, A.; Romagnolo, B.; Billuart, P.; Renard, C. A.; Buendia, M. A.; Soubrane, O.; Fabre, M.; Chelly, J.; Beldjord, C.; Kahn, A.; Perret, C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA. 95:8847-8851; 1998.
20. He, T. C.; Sparks, A. B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L. T.; Morin, P. J.; Vogelstein, B.; Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512; 1998.
21. Hugh, T. J.; Dillon, S. A.; O'Dowd, G.; Getty, B.; Pignatelli, M.; Poston, G. J.; Kinsella, A. R. β-catenin expression in primary and metastatic colorectal carcinoma. Int. J. Cancer 82:504-511; 1999.
22. Morin, P. J. β-catenin signaling and cancer. Bioessays 21:1021-1030; 1999.
23. Shapiro, L. β-catenin and its multiple partners: promiscuity explained. Nat. Struct. Biol. 8:484-487; 2001.
24. Omer, C. A.; Miller, P. J.; Diehl, R. E.; Kral, A. M. Identification of Tcf4 residues involved in high-affinity β-catenin binding. Biochem. Biophys. Res. Commun. 256: 584-590; 1999.
25. Hovanes, K.; Li, T. W.; Munguia, J. E.; Truong, T.; Milovanovic, T.; Lawrence Marsh, J.; Holcombe, R. F.; Waterman, M. L. β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28:53-57; 2001.
26. Behrens, J. Control of β-catenin signaling in tumor development. Ann. NY Acad. Sci. 910:21-33; 2000.
27. Fu, M.; Wang, C.; Li, Z.; Sakamaki, T.; Pestell, R. G. Minireview: Cyclin D1: Normal and abnormal functions. Endocrinology 145:5439-5447; 2004.
28. Tetsu, O.; McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426; 1999.
29. Nasi, S.; Ciarapica, R.; Jucker, R.; Rosati, J.; Soucek, L. Making decisions through Myc. FEBS Lett. 490:153-162; 2001.